A Randomized Phase III Trial of Adjuvant Chemotherapy with UFT following Curative Radiation Therapy for Locally Advanced Cervical Cancer
- Conditions
- Stage Ib2-IVa cervical cancer with Curative Radiation Therapy
- Registration Number
- JPRN-UMIN000003651
- Lead Sponsor
- Gynecologic Oncology Trial and Investigation Consortium
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- Female
- Target Recruitment
- 350
Not provided
1)Patients who have received hysterectomy after radiation therapy. 2)Patients with uterine stump cancer. 3)Patients who have received NAC. 4)Patients with active infection. 5)Patients who have myocardial infarction or unstable angina or uncontrolled arrhythmia within 6 months. 6)Patients with severe complications (uncontrolled hypertension,uncontrolled diabetes,bleeding tendency,or rheumatology). 7)Patients who have had any other cancer within the past 5 years. 8)Patients with watery diarrhea. 9)Patients with psychiatric disease. 10)Patients who are pregnant or breast feeding. 11)Patients who have a history of hypersensitivity to UFT 12)Patients who are considered to be inappropriate for this study judged by the treating physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Progression-free survival
- Secondary Outcome Measures
Name Time Method Overall Suvival/Adverse event/Quality of Life/Cost effectiveness